Company presents new pain data on the anti-inflammatory effects of its TrkA-NAM
Company presents new pain data on the anti-inflammatory effects of its TrkA-NAM
A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial
Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis
The two biotech leaders have embarked on a research project to streamline manufacturing
Therapy has been developed for the prevention of disease in infants
Celebrating excellence in clinical research for over decades.
Exploratory central nervous system analysis shows that ACD856 increases activity in brain
European wide research infrastructures, oncology experts and patient associations link up to combat cancer
The PRO-C6 biomarker assay has been transferred to Roche Diagnostics for further analysis
Study reveals first genetic links in chronic fatigue syndrome, paving the way for new drugs
Therapy is for the treatment of spasticity due to multiple sclerosis
Modelling indicates a 307% increase in cases identified between 2020 and 2021
Up-LIFT research achieves primary endpoint with improvement in arm and hand function
Collaboration will involve sophisticated screening for cardiac-based drug discovery